Empty Capsules Market Size and Growth Rate Analysis:
Empty Capsules Market size was worth USD 1685.2 million in 2019 and estimated to be growing at a CAGR of 7.57%, to reach USD 2428.6 million by 2024. The Empty Capsules Market is showcasing evident potential in the mentioned forecasting period. Empty Capsules are generally made from Gelatin, which is derived from plant or animal origin. These are used as dosage form for prescription and OTC drugs, nutrient supplements and herbal products.
Growth Drivers of the Empty Capsules Market:
Growth of empty capsules market is expected to be driven by growing applications in pharmaceutical and nutraceuticals companies. Technological advancements coupled with growing consumer preference towards capsule based formulations are also fueling the market growth. However increasing costs of raw material, stringent regulatory frameworks and religious issues concerned with the consumption of capsules containing animal derived ingredients are limiting the growth of the empty capsules market.
Empty Capsules Market Growth Based on Segment:
Gelatin Capsules is the largest product segment accounting for a share of approximately 80% whereas Non-Gelatin capsules is estimated to be the fastest segment with a CAGR of XX% due to increasing preference for vegetable origin capsules. Dietary supplements and vitamins segment is expected to be the fastest growing therapeutic application segment.
Segmentation of the Empty Capsules Market:
Empty Capsules Market Segmented – By Product:
Empty Capsules Market Segmented – By therapeutic application
Empty Capsules Market Segmented – Based on End User:
Geographical Segmentation of the Empty Capsules Market:
Regional Analysis of the Empty Capsules Market:
North America is the dominating market for Empty capsules accounting for a share of approximately 37% owing to rising consumer awareness and increase in the consumption of nutraceutical products. Asia-Pacific is estimated to be the fastest growing region due to increasing government support and increasing demand for nutraceuticals and cosmeceuticals.
Top Companies mentioned in this report are:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Gelatin Capsules
5.1.2 Non Gelatin Capsules
5.2 By Therapeutic Applcation
5.2.1 Antibiotic and Antibacterial Drugs
5.2.2 Vitamins and Dietary Supplements
5.2.3 Antacid and Antiflatulent Preparations
5.2.4 Antianemic Preparations
5.2.5 Anti-Inflammatory Drugs
5.2.6 Cardiovascular Therapy Drugs
5.2.7 Cough and Cold Preparations
5.2.8 Other therapeutic applications
5.3 By End User
5.3.1 Pharmaceutical Industry
5.3.2 Nutraceutical Industry
5.3.3 Cosmetics Industry
5.3.4 Research Laboratories
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Capsugel
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Suheung Co Ltd.
8.3 Acg Worldwide
8.4 Bright Pharmacaps Inc.
8.5 Capscanada Corporation
8.6 Medi-Caps Ltd.
8.7 Qualicaps
8.8 Roxlor, LLC
8.9 Snail Pharma Industry Co., Ltd.
8.10 Sunil Healthcare Limited
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
